Completed OBSERVATIONAL NCT05347992

ELEVATE - (Empower Lupus Erythematosus Patients Via Allowing RemoTe Evaluation) (ELEVATE)

Sponsor: DxTerity Diagnostics

Updated 6 times since 2022 Last updated: Jan 6, 2025 Started: May 3, 2022 Primary completion: May 25, 2023 Completion: Aug 17, 2023

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

This observational or N/A phase trial investigates Systemic Lupus Erythematosus and is currently completed. DxTerity Diagnostics leads this study, which shows 6 recorded versions since 2022 — indicating limited longitudinal coverage. The change history captured here reflects the iterative nature of clinical trial conduct.

Status Flow

Change History

6 versions recorded

Feb 2025 — Present [monthly]

Completed

Status: Active Not Recruiting → Completed
Sep 2024 — Feb 2025 [monthly]

Active Not Recruiting
Jul 2024 — Sep 2024 [monthly]

Active Not Recruiting
Mar 2023 — Jul 2024 [monthly]

Active Not Recruiting

Status: Recruiting → Active Not Recruiting
Jun 2022 — Mar 2023 [monthly]

Recruiting

Status: Not Yet Recruiting → Recruiting

▶ Show 1 earlier version

May 2022 — Jun 2022 [monthly]

Not Yet Recruiting

First recorded

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

DxTerity Diagnostics

Data source: DxTerity Diagnostics

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Compton, United States